Friday, 20 October 2017

DBV Technologies peanut allergy drug fails key study

(Reuters) - Drug developer DBV Technologies SA said on Friday its peanut allergy treatment did not meet the main goal in a highly anticipated late-stage study.


Posted by at

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)